InsidersTradesSigma
Total declarations
Company
▲ Purchases (6 ops.)
▼ Sales (0 ops.)
Insider track record
CEODisclosed buys
6
Disclosed sells
0
T+90 hit rate
33%
T+90 mean return
-33.3%
Across 3 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Browse the detailed record of transactions filed by Beattie John Gregory, Directeur Exécutif, Responsable des Opérations. Director active across 1 company, notably Inotiv, Inc.. Aggregated, 13 reports have been recorded. Breakdown: 6 buys · 0 sell. Total volume traded: €720k. Activity tracked since 7 May 2021. The latest transaction was disclosed on 19 July 2026 (J). Regulator: SEC (Form 4). All data is free.
Companies and markets linked to Beattie John Gregory
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations13 total
180,992 shares0Common StockSEC:0001845679-26-000004:0
5,769 sharesCommon StockSEC:0001845679-26-000002:0
25,000 shares0Common StockSEC:0001062993-25-005714:0
30,000 shares@ US$4.7514.4% of flowCommon StockSEC:0001062993-24-020560:0
Canonical exit: 10 Mar 2025 (T+90)
20,000 shares0Common StockSEC:0001062993-24-015130:0
47,966 shares@ US$3.123814.7% of flowCommon StockSEC:0001062993-23-022658:0
Canonical exit: 13 Mar 2024 (T+90)
5,000 shares@ US$6.993.5% of flowCommon StockSEC:0001062993-23-004773:0
Canonical exit: 23 May 2023 (T+90)
7,101 shares0Common StockSEC:0001062993-23-001184:0
8,900 shares@ US$22.3421.2% of flowCommon StockSEC:0001062993-22-019514:0
Canonical exit: 8 Dec 2022 (T+90)
5,800 shares@ US$23.71110.24% mcap28.0% of flowCommon SharesSEC:0001179110-22-001465:0
Canonical exit: 17 May 2022 (T+90)
954 shares0Common SharesSEC:0001179110-21-009621:0
5,000 shares@ US$22.9113.2% of flowCommon SharesSEC:0001179110-21-005395:0
Canonical exit: 11 Aug 2021 (T+90)
440 shares0Common SharesSEC:0001179110-21-005174:0
13 of 13 declarations
About Beattie John Gregory
John Gregory Beattie is the Chief Operating Officer at Inotiv, Inc. In this role, he oversees the daily operations of the company and ensures that strategic objectives are met. John brings significant experience in the life sciences sector, contributing to process improvement and operational efficiency at Inotiv. His leadership is essential for the company's success.
